Prolonged QT interval with rivastigmine.
Walsh
E
E
Dourish
J
J
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy; D002219:Carbamates / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008297:Male; D018696:Neuroprotective Agents / Q000009:adverse effects*; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine